Schrodinger (NASDAQ:SDGR – Get Free Report) will likely be posting its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Schrodinger to post earnings of ($0.4145) per share and revenue of $47.1860 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:30 PM ET.
Schrodinger (NASDAQ:SDGR – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported ($0.81) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.25). Schrodinger had a negative net margin of 40.61% and a negative return on equity of 30.85%. The company had revenue of $58.59 million for the quarter, compared to the consensus estimate of $47.57 million. During the same quarter in the previous year, the firm posted ($0.82) earnings per share. The business’s revenue for the quarter was down 1.6% compared to the same quarter last year. On average, analysts expect Schrodinger to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Schrodinger Price Performance
Shares of NASDAQ SDGR opened at $15.14 on Monday. Schrodinger has a 52 week low of $10.94 and a 52 week high of $23.02. The business has a 50-day simple moving average of $15.40 and a two-hundred day simple moving average of $13.74. The company has a market cap of $1.12 billion, a P/E ratio of -10.74 and a beta of 1.62.
Hedge Funds Weigh In On Schrodinger
Analyst Upgrades and Downgrades
A number of research firms have recently commented on SDGR. KeyCorp cut their price objective on shares of Schrodinger from $25.00 to $20.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Weiss Ratings raised shares of Schrodinger from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday. Morgan Stanley lowered their target price on shares of Schrodinger from $19.00 to $17.00 and set an “equal weight” rating on the stock in a research note on Thursday, May 14th. Finally, Wall Street Zen lowered shares of Schrodinger from a “hold” rating to a “strong sell” rating in a research report on Saturday, May 9th. Four analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $20.25.
View Our Latest Stock Analysis on Schrodinger
Schrodinger Company Profile
Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.
Recommended Stories
- Five stocks we like better than Schrodinger
- 3 Low-Volatility Plays Quietly Making a Name For Themselves
- ASML’s Dividend Growth Adds a Quiet Income Angle to Its AI Chip Story
- 2 Consumer Staples Stocks Giving Investors a Break From the AI Trade
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
